Operating Lease, Right-of-Use Asset in USD of SINOVAC BIOTECH LTD from Q4 2018 to Q4 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: SINOVAC BIOTECH LTD quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q4 2023.
SINOVAC BIOTECH LTD Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2023 was $45.5M, a 22.3% decline year-over-year.

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

SINOVAC BIOTECH LTD Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$45.5M	-$13.1M	-22.3%	31 Dec 2023	20-F	29 Apr 2024
Q4 2022	$58.6M	-$56.8M	-49.2%	31 Dec 2022	20-F	29 Apr 2024
Q4 2021	$115M	+$31.5M	+37.6%	31 Dec 2021	20-F	01 May 2023
Q4 2020	$83.8M	+$77.2M	+1163%	31 Dec 2020	20-F	29 Apr 2022
Q4 2019	$6.64M	+$6.64M		31 Dec 2019	20-F	22 Apr 2021
Q4 2018	$0			31 Dec 2018	20-F	30 Apr 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.